Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Drug development

Uniquity Bio
Research

Uniquity Bio Advances Esophageal Drug Toward Phase 3 Trial

November 18, 2026November 18, 2026 - by Timothy Alexander

MALVERN, PA — Uniquity Bio plans to begin a pivotal Phase 3 trial of its experimental esophageal disease treatment in early 2027 after reporting statistically significant improvements in swallowing symptoms …

Uniquity Bio Advances Esophageal Drug Toward Phase 3 Trial Read More

ArriVent BioPharma
Regional / Research

ArriVent Advances Cancer Drug Pipeline With First U.S. Trial

October 19, 2026October 19, 2026 - by Timothy Alexander

NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) has dosed the first patient in a U.S. Phase 1 clinical trial of ARR-002, an experimental antibody-drug conjugate targeting ovarian and …

ArriVent Advances Cancer Drug Pipeline With First U.S. Trial Read More
Medicus Pharma
Regional

ICYMI: Medicus Pharma Faces Clinical Test After Raising $90 Million

October 15, 2026October 13, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has raised approximately $90 million through equity and debt financing over three years to build a diversified drug-development portfolio, leaving the biotechnology …

ICYMI: Medicus Pharma Faces Clinical Test After Raising $90 Million Read More

Medicus Pharma
Regional

Medicus Pharma Shifts Focus to Oncology Amid Stock Volatility

October 10, 2026October 10, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) is concentrating its drug-development investments on targeted cancer therapies while pursuing partnerships to limit future financing requirements, a strategic shift that follows …

Medicus Pharma Shifts Focus to Oncology Amid Stock Volatility Read More
Food and Drug Administration
National / Research

FDA Opens Expedited Drug Trial Pilot to Cut Development Delays

September 21, 2026September 21, 2026 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration finalized an expedited regulatory pilot that will pair drug companies with qualified research institutions to shorten the path to first-in-human clinical …

FDA Opens Expedited Drug Trial Pilot to Cut Development Delays Read More

Palvella Therapeutics
Health / Medical

Palvella Executive to Address FDA Drug Repurposing Barriers

August 4, 2026August 4, 2026 - by Timothy Alexander

WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Scientific Officer Jeffrey Martini will address evidence gaps and regulatory barriers affecting drug repurposing at an Aug. 5 FDA public workshop …

Palvella Executive to Address FDA Drug Repurposing Barriers Read More
Traws Pharma
Regional

Traws Advances Broad-Spectrum Antiviral as Outbreak Risks Grow

June 3, 2026June 2, 2026 - by Timothy Alexander

NEWTOWN, PA — Traws Pharma (Nasdaq: TRAW) is advancing development of a broad-spectrum antiviral combination designed to target multiple high-risk viral diseases, including hantavirus, Ebola, and Lassa fever, as the …

Traws Advances Broad-Spectrum Antiviral as Outbreak Risks Grow Read More

Food and Drug Administration
National

FDA Moves to Cut Animal Testing for Some Cancer Drugs

May 31, 2026May 31, 2026 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration has proposed reducing animal testing requirements for certain cancer therapies, a shift that could lower development costs and shorten preclinical timelines …

FDA Moves to Cut Animal Testing for Some Cancer Drugs Read More
puppy leaning on the fence
National

FDA Push to Cut Animal Testing Shows Early Progress

April 27, 2026April 26, 2026 - by Maryann Pugh

WASHINGTON, D.C. — Federal regulators say efforts to reduce animal testing in drug development are advancing, with the Food and Drug Administration reporting early progress on a plan aimed at …

FDA Push to Cut Animal Testing Shows Early Progress Read More
Charcot-Marie-Tooth Association
Regional

$100,000 Bet on Breakthrough: CMTA Backs Early CMT1A Drug Hope

January 3, 2026January 2, 2026 - by Timothy Alexander

GLENOLDEN, PA — The Charcot-Marie-Tooth Association has committed $100,000 to EverTree Bio, deepening its push to turn early scientific promise into potential treatments for Charcot-Marie-Tooth disease Type 1A, the most …

$100,000 Bet on Breakthrough: CMTA Backs Early CMT1A Drug Hope Read More

Posts pagination

1 2 Next

Trending News

  • Camp Saginaw Withdraws New London Township Cell Tower Plan

  • Chadds Ford Art Museum Adds Outdoor Ice Rink for the Holidays

  • Coatesville Woman Pleads Guilty to Voting Illegally Twice

  • West Chester University’s Holiday Concert Adds Second Show

  • Put Your Finances in Position for 2027

Subscribe for Updates

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Court News

Coatesville Woman Pleads Guilty to Voting Illegally Twice

November 20, 2026November 19, 2026

acw woman report

Pennsylvania Report Calls for Paid Leave, Workplace Reforms

November 20, 2026November 19, 2026

Courthouse

New York Man Accused of Supplying Cocaine to Penn State Fraternities

November 19, 2026November 19, 2026

Copyright © 2026 MyChesCo.